08/14/2024 7:29 AM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 3:21 PM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 8:51 PM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 6:26 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 5:53 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 5:57 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024 4:27 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/19/2024 4:30 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 4:12 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024 6:07 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 3:41 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024 4:37 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 3:57 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 3:38 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 7:58 PM | ANI Pharmaceuticals (Issuer) Gassert Chad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 5:56 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2024 6:11 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:46 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024 3:37 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024 4:23 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 3:51 PM | ANI Pharmaceuticals (Issuer) Marken James G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 5:21 PM | ANI Pharmaceuticals (Issuer) Gutwerg Ori (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2024 6:34 AM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 5:08 PM | ANI Pharmaceuticals (Issuer) Gassert Chad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 3:35 PM | ANI Pharmaceuticals (Subject) CAREY STEPHEN P. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024 6:54 PM | ANI Pharmaceuticals (Issuer) Leonard Matthew J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:58 PM | ANI Pharmaceuticals (Issuer) Pera Antonio R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:59 PM | ANI Pharmaceuticals (Issuer) TANNENBAUM RENEE P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 7:02 PM | ANI Pharmaceuticals (Issuer) Thoma Jeanne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 7:03 PM | ANI Pharmaceuticals (Issuer) Walsh Patrick D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/23/2024 6:45 PM | ANI Pharmaceuticals (Issuer) HAUGHEY THOMAS (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 5:14 PM | ANI Pharmaceuticals (Issuer) Mutz Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:21 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 5:01 PM | ANI Pharmaceuticals (Issuer) TANNENBAUM RENEE P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 5:05 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 3:50 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 4:02 PM | ANI Pharmaceuticals (Issuer) Lalwani Nikhil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 4:02 PM | ANI Pharmaceuticals (Subject) TANNENBAUM RENEE P (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024 3:59 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024 6:47 PM | ANI Pharmaceuticals (Subject) Lalwani Nikhil (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9318&Placement=NativeDisplay&Source=NativeDisplay) Click here to see a unique election-year trade |
05/13/2024 4:25 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 6:09 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024 5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/22/2024 5:26 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 3:43 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024 3:50 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024 3:33 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:19 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024 6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:41 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024 8:33 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024 5:28 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 8:12 PM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 8:13 PM | ANI Pharmaceuticals (Issuer) Marken James G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 8:53 PM | ANI Pharmaceuticals (Issuer) Rowland Thomas Andrew (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/05/2024 3:42 PM | ANI Pharmaceuticals (Filer)
| Form ARS | |
04/02/2024 5:59 PM | ANI Pharmaceuticals (Issuer) Gassert Chad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 3:17 PM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 3:09 PM | ANI Pharmaceuticals (Issuer) Lalwani Nikhil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 6:30 AM | ANI Pharmaceuticals (Subject) Meridian Venture Partners II GP, L.P. (Filed by)
| Form SC 13D/A | |
03/13/2024 3:44 PM | ANI Pharmaceuticals (Issuer) Gassert Chad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:48 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 6:07 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 5:58 PM | ANI Pharmaceuticals (Subject) CAREY STEPHEN P. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 5:39 PM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 5:43 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 6:25 PM | ANI Pharmaceuticals (Issuer) Lalwani Nikhil (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 4:59 PM | ANI Pharmaceuticals (Subject) Lalwani Nikhil (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024 8:42 PM | ANI Pharmaceuticals (Issuer) Marken James G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:21 PM | ANI Pharmaceuticals (Issuer) Gutwerg Ori (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:11 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 8:16 PM | ANI Pharmaceuticals (Issuer) Mutz Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:58 PM | ANI Pharmaceuticals (Subject) Lalwani Nikhil (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 4:31 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 3:24 PM | ANI Pharmaceuticals (Issuer) Mutz Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 3:20 PM | ANI Pharmaceuticals (Issuer) Pera Antonio R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:18 PM | ANI Pharmaceuticals (Subject) Pera Antonio R (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 4:09 PM | ANI Pharmaceuticals (Issuer) Marken James G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:12 PM | ANI Pharmaceuticals (Issuer) Mutz Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:18 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 3:55 PM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:22 AM | ANI Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 5:58 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/23/2024 3:51 PM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 3:47 PM | ANI Pharmaceuticals (Issuer) Marken James G. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:50 PM | ANI Pharmaceuticals (Issuer) Mutz Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:53 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:34 PM | ANI Pharmaceuticals (Issuer) Gassert Chad (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:38 PM | ANI Pharmaceuticals (Issuer) Gutwerg Ori (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:26 PM | ANI Pharmaceuticals (Issuer) CAREY STEPHEN P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9318&Placement=NativeDisplay&Source=NativeDisplay) Click here to see a unique election-year trade |
02/13/2024 7:05 PM | ANI Pharmaceuticals (Issuer) Cook Meredith (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 5:06 AM | ANI Pharmaceuticals (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G | |
02/08/2024 7:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2024 5:14 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024 4:32 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 3:52 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024 3:30 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 5:20 PM | ANI Pharmaceuticals (Issuer) Shanmugam Muthusamy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/18/2024 4:06 PM | ANI Pharmaceuticals (Subject) Shanmugam Muthusamy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |